Leggat McCall Properties

Leggat McCall Properties is a prominent private real estate investment and development firm headquartered in Boston. Founded in 1995, the company has established a significant presence in the New England market, focusing on complex urban projects, life sciences facilities, and transformative mixed-use developments. Its portfolio encompasses millions of square feet of commercial, residential, and laboratory space, contributing substantially to the physical and economic landscape of the Greater Boston area and beyond.

History

The firm was established in 1995 by veterans of the Boston real estate scene, Robert H. Sheridan Jr. and Brian P. Dacey. Its early growth was closely tied to the revitalization of Boston's urban core, participating in key projects during the city's economic resurgence. A significant early milestone was its role in the redevelopment of the former Charlestown Navy Yard, transforming historic military structures into modern office and research space. Throughout the late 1990s and 2000s, the company expanded its expertise into life sciences real estate, capitalizing on the booming biotechnology sector anchored by institutions like MIT and Harvard University. This strategic pivot positioned it as a leading developer for major academic, medical, and corporate clients, including Novartis, Pfizer, and Boston Children's Hospital.

Notable projects

The company's project portfolio is distinguished by large-scale, often catalytic developments. In Kendall Square, it developed 325 Main Street, a major life sciences building, and was the development manager for the MIT-anchored University Park. In Boston's Seaport District, it led the development of the 17-acre, mixed-use Seaport Square project, one of the largest private developments in the city's history, which includes office towers, residential buildings, and retail space. Other significant projects include the redevelopment of the Former Necco Factory in Cambridge into innovation space, the Cambridge Discovery Park, and the Bulfinch Crossing complex in downtown Boston, which replaced the aging Government Center Garage with modern towers. It has also executed major projects for Partners HealthCare and Brigham and Women's Hospital.

Business model and operations

The firm operates primarily as a fee-based developer and investment manager, rather than a long-term holder of equity. Its core services include development management, where it oversees the entire process from site acquisition and entitlements to construction and leasing for institutional clients. It also engages in investment management, forming discretionary funds and joint ventures with capital partners like AEW Capital Management and Manulife Financial to pursue development and value-add opportunities. A key operational focus is the life sciences sector, where it provides specialized expertise in designing and building complex laboratory and research facilities that meet stringent technical requirements for clients in the biotechnology and pharmaceutical industries.

Leadership and corporate structure

Leadership has remained stable since its founding, with Robert H. Sheridan Jr. serving as Chairman and Chief Executive Officer and Brian P. Dacey as President. Both principals are well-known figures in New England real estate circles and are actively involved in civic organizations such as the Greater Boston Chamber of Commerce and the Museum of Science, Boston. The firm is privately held and maintains a streamlined corporate structure, organizing its activities around dedicated teams for development, investments, and asset management. This structure is designed to foster deep client relationships and allow for agile decision-making on complex projects.

Impact and recognition

The company has had a substantial impact on the urban form and economic vitality of Greater Boston, particularly in transforming underutilized industrial and parking areas into vibrant, dense, mixed-use neighborhoods like the Seaport District and Kendall Square. Its focus on life sciences development has supported the growth of the region's premier innovation economy, providing critical infrastructure for the Massachusetts biotechnology cluster. The firm and its leaders have received numerous industry awards, including honors from the National Association of Industrial and Office Properties (NAIOP) and the Urban Land Institute (ULI). Its projects are frequently cited for their design quality and contribution to sustainable, walkable urban environments.

Category:Real estate companies of the United States Category:Companies based in Boston Category:Real estate development companies